ESMO 2025: OncoDaily LIVE Coverage
What Drives Science and What Guides Care? Redefining Glioma Treatment in 2025
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025
RC48-C016 at ESMO 2025: DV Plus Toripalimab Increases Survival vs Chemotherapy in HER2-Expressing Urothelial Cancer
Fumiko Ladd Chino: New Paper on Overlooked and Marginalized Communities
FLAURA2 Trial: Osimertinib Plus Chemotherapy Improves Overall Survival Across Prognostic Subgroups in EGFR-Mutated Advanced NSCLC — Presented at ESMO 2025
Mikkael Sekeres was Elected to the ASH Executive Committee - Sylvester Comprehensive Cancer Center
SIOP Board of Directors Meet in Amsterdam to Shape the Future of Global Childhood Cancer Care
